The Comprehensive Pancreas Program aims to provide the best possible clinical care and to achieve the best outcomes for patients with pancreatic disorders to improve their quality of life. To achieve these goals, we have committed ourselves to excellence in patient-centered clinical care, education, innovative research, and multidisciplinary collaboration.
A Message From Our Director
Since Dr. Marvin Pollard, the first Gastroenterology Division Chief (1947-1972), Michigan Medicine has been a leader in pancreas related patient care, research, and education. The Comprehensive Pancreas Program in Gastroenterology has over 45 faculty members from multiple departments, many known for clinical excellence and national leadership. We are dedicated to improving the lives of our patients, advancing research, and educating the physicians of tomorrow.
The Pancreas Clinic evaluation begins with a patient–physician interview, standardized data gathering, entry of data into a patient registry, and targeted care with multidisciplinary faculty from Gastroenterology, Endocrinology, Surgery, Radiology, Pathology and Oncology. We review complex cases during a bimonthly, multidisciplinary benign pancreas conference and weekly multidisciplinary pancreatic cancer conference to discuss patients’ diagnoses and their appropriate treatment of pain, nutrition, diabetes, substance abuse, and cancer risk.
Research is supported by the National Institutes of Health (NIH) and other sources of extramural funding. Our clinical research focuses on acute pancreatitis, chronic pancreatitis, exocrine pancreatic insufficiency, pancreatic cysts and biomarkers for diagnosis of pancreatic cancer. Basic science areas include regulation of exocrine pancreatic secretion, mechanisms and translational therapies for pancreatitis and pain, pancreatic inflammation, and tumorigenesis.
The University of Michigan is one of over 50 National Pancreas Foundation (NPF) centers of excellence for pancreatitis in the country and the only one in the state of Michigan. To train the next generation, we anticipate offering a 1-year Pancreatology Fellowship Training Program to develop expertise in managing the spectrum of pancreatitis, exocrine pancreatic insufficiency, cystic fibrosis associated GI disorders, pancreatic cysts, and (pre)malignant pancreatic conditions. This fellowship program will complement an existing 1-year Advanced Endoscopy Fellowship Training Program.
I invite you to explore our website and contact us to learn more!
Matthew J. DiMagno, MD
Director, Comprehensive Pancreas Program in Gastroenterology